Rajapillai Pillai, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptor, Serotonin, 5-HT1A | 3 | 2018 | 58 | 1.320 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2023 | 109 | 0.760 |
Why?
|
Loudness Perception | 1 | 2020 | 23 | 0.710 |
Why?
|
Depressive Disorder, Major | 4 | 2019 | 4767 | 0.700 |
Why?
|
Lead Poisoning | 1 | 2022 | 323 | 0.680 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2020 | 325 | 0.600 |
Why?
|
Evoked Potentials, Auditory | 1 | 2020 | 531 | 0.540 |
Why?
|
Anaphylaxis | 1 | 2023 | 758 | 0.500 |
Why?
|
Serotonin | 1 | 2020 | 1042 | 0.490 |
Why?
|
Autistic Disorder | 1 | 2022 | 1222 | 0.420 |
Why?
|
Social Stigma | 1 | 2019 | 770 | 0.420 |
Why?
|
Faculty, Medical | 1 | 2019 | 1205 | 0.370 |
Why?
|
Positron-Emission Tomography | 4 | 2020 | 6586 | 0.340 |
Why?
|
Family | 1 | 2020 | 3192 | 0.330 |
Why?
|
Education, Medical | 1 | 2020 | 1725 | 0.310 |
Why?
|
Drug Discovery | 1 | 2016 | 1048 | 0.300 |
Why?
|
Brain | 3 | 2020 | 27094 | 0.290 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 562 | 0.270 |
Why?
|
Students, Medical | 1 | 2019 | 1940 | 0.270 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3885 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4014 | 0.240 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2813 | 0.230 |
Why?
|
Septum Pellucidum | 1 | 2023 | 55 | 0.210 |
Why?
|
Mental Disorders | 2 | 2019 | 6823 | 0.200 |
Why?
|
Environmental Health | 1 | 2022 | 289 | 0.170 |
Why?
|
Dissent and Disputes | 1 | 2020 | 148 | 0.160 |
Why?
|
Raphe Nuclei | 1 | 2019 | 104 | 0.160 |
Why?
|
Serotonin 5-HT1 Receptor Antagonists | 1 | 2018 | 9 | 0.150 |
Why?
|
Autoreceptors | 1 | 2018 | 5 | 0.150 |
Why?
|
Radiopharmaceuticals | 2 | 2018 | 2684 | 0.150 |
Why?
|
Sertraline | 1 | 2019 | 209 | 0.150 |
Why?
|
Anisotropy | 1 | 2019 | 1284 | 0.130 |
Why?
|
Patient Care | 1 | 2020 | 623 | 0.120 |
Why?
|
Organ Size | 1 | 2017 | 2253 | 0.100 |
Why?
|
Amygdala | 1 | 2019 | 1353 | 0.090 |
Why?
|
Humans | 12 | 2023 | 761222 | 0.090 |
Why?
|
Adult | 6 | 2020 | 221120 | 0.090 |
Why?
|
Length of Stay | 1 | 2023 | 6417 | 0.080 |
Why?
|
Environmental Exposure | 1 | 2022 | 4479 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2522 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2017 | 2401 | 0.070 |
Why?
|
Male | 6 | 2023 | 360703 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2893 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 3805 | 0.070 |
Why?
|
Neural Pathways | 1 | 2017 | 3056 | 0.070 |
Why?
|
Hippocampus | 1 | 2019 | 3754 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9187 | 0.060 |
Why?
|
Pyridines | 1 | 2017 | 2872 | 0.060 |
Why?
|
Child | 3 | 2023 | 80154 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1663 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3366 | 0.060 |
Why?
|
Middle Aged | 4 | 2020 | 220858 | 0.060 |
Why?
|
Electroencephalography | 1 | 2020 | 6242 | 0.060 |
Why?
|
Hospitalization | 1 | 2023 | 10707 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5092 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 26200 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14675 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20118 | 0.050 |
Why?
|
Child, Preschool | 1 | 2023 | 42225 | 0.040 |
Why?
|
Female | 3 | 2020 | 392552 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2023 | 80675 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2022 | 1510 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 59222 | 0.030 |
Why?
|
Adolescent | 1 | 2020 | 88300 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36415 | 0.020 |
Why?
|
Aged | 1 | 2020 | 169292 | 0.020 |
Why?
|
Animals | 1 | 2016 | 168089 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|